Target intelligence / Profile preview

Cathepsin B pseudogene

Molecular classification: Other (Pseudogene)

Overview

The cathepsin B pseudogene (ENSG00000228729, LOC100418874) is a non-coding genomic sequence related to the cathepsin B gene (CTSB), which encodes a cysteine protease involved in lysosomal protein degradation, cancer invasion, and neurodegeneration[1][3][8]. As a pseudogene, ENSG00000228729 does not produce a functional protein and is not itself involved in molecular, cellular, or disease processes. Pseudogenes like this arise by duplication or mutation and are generally transcriptionally silent, lacking biological activity and therapeutic relevance.

Other names: LOC100418874Cathepsin B pseudogeneENSG00000228729

Beyond the preview

Go deeper on Cathepsin B pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cathepsin B pseudogene.

Explore the full profile